Related Experiment Videos
Adrenocortical carcinoma in children
The Journal of Urology
|December 1, 1983
Summary
Childhood adrenocortical carcinoma is rare but serious. Early detection, surgery, and treatments like mitotane show promise for improving survival rates in pediatric patients.
Area of Science:
- Pediatric Oncology
- Endocrinology
Background:
- Childhood adrenocortical carcinoma is a rare and often fatal endocrine tumor.
- Presentation varies, including hormonal excess or acute abdominal symptoms.
Purpose of the Study:
- To report on the detection and management of five pediatric adrenocortical carcinoma cases.
- To evaluate the safety and efficacy of adjuvant mitotane therapy in children.
Main Methods:
- Retrospective case series of five children diagnosed with adrenocortical carcinoma.
- Surgical tumor resection followed by adjuvant therapy with mitotane in four patients.
- Chemotherapy was also utilized in some cases.
Main Results:
- Four patients presented with signs of excess corticosteroid production; one had acute abdominal pain.
- All tumors were surgically removed.
- Two patients survived, while three succumbed to the disease. Mitotane was safely administered.
Conclusions:
- Adrenocortical carcinoma in children requires aggressive management.
- Early diagnosis, surgical extirpation, and adjuvant therapy with mitotane and chemotherapy may improve survival outcomes.